Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.70B | 6.57B | 6.58B | 6.51B | 6.34B |
| Total Depreciation and Amortization | 2.78B | 2.79B | 2.87B | 2.98B | 3.11B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.00M | -52.00M | -352.00M | -335.00M | -397.00M |
| Change in Net Operating Assets | -1.81B | -1.66B | -1.53B | -1.02B | -379.00M |
| Cash from Operations | 7.82B | 7.65B | 7.58B | 8.14B | 8.67B |
| Capital Expenditure | -1.53B | -1.54B | -1.41B | -1.42B | -1.40B |
| Sale of Property, Plant, and Equipment | 44.00M | 34.00M | 50.00M | 65.00M | 57.00M |
| Cash Acquisitions | -4.04B | -4.04B | -3.13B | -3.13B | -3.13B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.47B | 625.00M | 117.00M | 144.00M | -1.37B |
| Cash from Investing | -4.05B | -4.92B | -4.37B | -4.34B | -5.84B |
| Total Debt Issued | 8.85B | 3.94B | 2.84B | 2.84B | 1.20B |
| Total Debt Repaid | -3.51B | -4.72B | -5.23B | -4.45B | -3.61B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.00B | -3.96B | -3.00B | -3.00B | -4.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -636.00M | -623.00M | -610.00M | -597.00M | -583.00M |
| Other Financing Activities | 90.00M | -18.00M | 53.00M | 130.00M | 194.00M |
| Cash from Financing | 1.80B | -5.39B | -5.95B | -5.07B | -6.79B |
| Foreign Exchange rate Adjustments | 267.00M | 0.00 | 250.00M | -76.00M | -91.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | -1.00M | 0.00 | 1.00M | 0.00 |
| Net Change in Cash | 5.84B | -2.66B | -2.49B | -1.35B | -4.06B |